Get started
Author

Virginia Delucchi

Observed name: V. Delucchi
ORCID: 0009-0001-7729-4559
Observed ORCID: 0009-0001-7729-4559
OpenAlex ID: A5098677433
Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses
2025 · G. Rossi, L. Barcellini, et al. · ESMO Open · 17
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world
2025 · E. Blondeaux, L. Boni, et al. · ESMO Open · 17
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers
2025 · M. Perachino, E. Blondeaux, et al. · ESMO Open · 8
PDF
Breastfeeding after breast cancer in young BRCA carriers
2025 · Eva Blondeaux, Virginia Delucchi, et al. · JNCI Journal of the National Cancer Institute · 7
PDF
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study
2025 · A. Toss, E. Blondeaux, et al. · Annals of Oncology · 5
PDF
1815O Breastfeeding after breast cancer in young BRCA carriers: Results from an international cohort study
2024 · E. Blondeaux, V. Delucchi, et al. · Annals of Oncology · 4
Physicians’ knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 survey
2025 · Simone Nardin, Luca Arecco, et al. · The Breast · 3
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study
2026 · Carlotta Becherini, Eva Blondeaux, et al. · Radiotherapy and Oncology · 2
PDF
330P Association of type of chemotherapy with survival outcomes in young BRCA1/2 carriers with HER2-negative early breast cancer: A secondary analysis of the BRCA BCY collaboration
2025 · R. Bernstein Molho, E. Blondeaux, et al. · Annals of Oncology · 1
The impact of ovarian function suppression with adjuvant endocrine therapy on survival outcomes in young germline BRCA mutation carriers with breast cancer: Secondary analysis of an international cohort study.
2025 · Paola Zagami, Yara Abdou, et al. · Journal of Clinical Oncology · 1
Association between type of BRCA1/2 pathogenic/likely pathogenic variants and outcome in young patients with breast cancer: Results from an international cohort study.
2025 · Angela Toss, Eva Blondeaux, et al. · Journal of Clinical Oncology · 1
4041 Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer
2025 · Carlotta Becherini, Eva Blondeaux, et al. · Radiotherapy and Oncology · 1
Effect of dose-dense adjuvant chemotherapy in patients with node-positive early breast cancer according to estrogen receptor levels: an exploratory analysis of the GIM2 trial
2026 · Carmine De Angelis, Alessandra Rosa, et al. · The Breast
PDF
Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers
2026 · Stephanie M. Wong, Eva Blondeaux, et al. · JAMA Network Open
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis
2026 · Davide Massa, Edoardo Chiappe, et al. · JNCI Journal of the National Cancer Institute
Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer
2026 · Rinat Bernstein-Molho, Tal Sella, et al. · European Journal of Cancer
PDF
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial
2026 · Chiara Molinelli, Virginia Delucchi, et al. · The Breast
PDF
Impact of BRCA pathogenic variants and novel targeted agents on ovarian reserve measured by anti-Müllerian hormone levels in young women with early breast cancer: A biomarker analysis of the PREFER study.
2026 · Luca Arecco, Arianna Meacci, et al. · Journal of Clinical Oncology
PDF
End‑of‑life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center
2026 · Michela De Mattia, Andrea Boutros, et al. · BMC Cancer
Abstract PD4-07: Association between age at diagnosis and survival among young BRCA carriers with breast cancer: results from an international multicenter hospital-based cohort study
2026 · E. Blondeaux, A. Meacci, et al. · Clinical Cancer Research
Abstract PD12-01: Surgical management of young BRCA1/2 carriers with early onset breast cancer
2026 · S. M. Wong, E. Blondeaux, et al. · Clinical Cancer Research
Abstract PS3-07-19: Impact of Endocrine Therapy in Estrogen Receptor-Low Breast Cancer: A Systematic Review and Meta-Analysis
2026 · D. Massa, E. Chiappe, et al. · Clinical Cancer Research
Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studies
2025 · Fernanda Mesa-Chavez, Maria Grazia Razeti, et al. · The Breast
Response to: Survival after risk-reducing mastectomy in young BRCA1 carriers with breast cancer
2025 · Virginia Delucchi, Matteo Lambertini, et al. · BJC Reports
PDF
2279MO Discontinuation and attrition rates in phase II or phase III first-line randomized clinical trials (RCTs) of solid tumors
2025 · E. Blondeaux, V. Delucchi, et al. · Annals of Oncology
Works count: 34
Citation count: 66
H-index: 5
I10-index: 2
Year
Topic
Type